A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders (Q36362041)

13 August 2017

1 reference

title

A critical reappraisal of the WHO classification of the chronic myeloproliferative disorders (English)

1 reference

World Health Organization

13 August 2017

main subject

0 references

author name string

Juergen Thiele

series ordinal

1

1 reference

13 August 2017

Hans M Kvasnicka

series ordinal

2

1 reference

13 August 2017

publication date

1 March 2006

1 reference

13 August 2017

1 reference

13 August 2017

volume

47

1 reference

13 August 2017

issue

3

1 reference

13 August 2017

page(s)

381-396

1 reference

Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Diagnosis and classification of erythrocytoses and thrombocytoses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Evolution of myelofibrosis in chronic idiopathic myelofibrosis as evidenced in sequential bone marrow biopsy specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Agnogenic myeloid metaplasia (AMM)--correlation of bone marrow lesions with laboratory data: a longitudinal clinicopathological study on 114 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The Italian Consensus Conference on Diagnostic Criteria for Myelofibrosis with Myeloid Metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis with myeloid metaplasia following essential thrombocythaemia: actuarial probability, presenting characteristics and evolution in a series of 195 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis with myeloid metaplasia: new developments in pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Modern management of myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Clinical and pathological criteria for the diagnosis of essential thrombocythemia, polycythemia vera, and idiopathic myelofibrosis (agnogenic myeloid metaplasia).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Treatment paradigms in the management of myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Treatment of essential thrombocythemia with special emphasis on leukemogenic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Current opinion in essential thrombocythemia: pathogenesis, diagnosis, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Thrombotic complications in essential thrombocythemia with relatively low platelet counts

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Therapeutic choices in younger patients with chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Prediction of initial cytogenetic response for subsequent major and complete cytogenetic response to imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Survival advantage with imatinib mesylate therapy in chronic-phase chronic myelogenous ;eukemia (CML-CP) after IFN-alpha failure and in late CML-CP, comparison with historical controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Imatinib mesylate therapy improves survival in patients with newly diagnosed Philadelphia chromosome-positive chronic myelogenous leukemia in the chronic phase: comparison with historic data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The histopathology of chronic myeloproliferative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Issues in the pathology and diagnosis of the chronic myeloproliferative disorders and the myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Sea-blue histiocytes and Gaucher cells in bone marrow of patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Frequency of pseudo-Gaucher cells in diagnostic bone marrow biopsies from patients with Ph-positive chronic myeloid leukaemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Clinicopathological impact of the interaction between megakaryocytes and myeloid stroma in chronic myeloproliferative disorders: a concise update

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Bone marrow features improve prognostic efficiency in multivariate risk classification of chronic-phase Ph(1+) chronic myelogenous leukemia: a multicenter trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Prognostic impact of bone marrow erythropoietic precursor cells and myelofibrosis at diagnosis of Ph1+ chronic myelogenous leukaemia--a multicentre study on 495 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Histochemistry and morphometry on bone marrow biopsies in chronic myeloproliferative disorders - aids to diagnosis and classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis in Chronic Granulocytic Leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Marrow fibrosis, indicator of therapy failure in chronic myeloid leukemia – prospective long-term results from a randomized-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

A new prognostic score for survival of patients with chronic myeloid leukemia treated with interferon alfa. Writing Committee for the Collaborative CML Prognostic Factors Project Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Proposal of a morphologic bone marrow response score for imatinib mesylate treatment in chronic myelogenous leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Megakaryopoiesis and myelofibrosis in chronic myeloid leukemia after allogeneic bone marrow transplantation: an immunohistochemical study of 127 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Megakaryocytopoiesis in haematological disorders: diagnostic features of bone marrow biopsies. An overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Blast count and cytogenetics correlate and are useful parameters for the evaluation of different phases in chronic myeloid leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Polycythemia vera: myths, mechanisms, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Guidelines for the diagnosis, investigation and management of polycythaemia/erythrocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The diagnosis and management of polycythemia vera in the era since the Polycythemia Vera Study Group: a survey of American Society of Hematology members' practice patterns

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Differentiation between essential thrombocythemia and polycythemia vera with marked thrombocytosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Classification and staging of Ph-negative myeloproliferative disorders by histopathology from bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Initial (latent) polycythemia vera with thrombocytosis mimicking essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Discrimination of polycythemias and thrombocytoses by novel, simple, accurate clonality assays and comparison with PRV-1 expression and BFU-E response to erythropoietin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The classification and diagnostic criteria of the erythrocytoses (polycythaemias)

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Serum erythropoietin values in erythrocytoses and in primary thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Serum erythropoietin values and endogenous erythroid colony growth in erythrocytoses and essential thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Standardization and comparison of endogenous erythroid colony assays performed with bone marrow or blood progenitors for the diagnosis of polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Diagnosis and treatment of polycythemia vera and possible future study designs of the PVSG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

PRV-1 mRNA expression discriminates two types of essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Identification of an acquired JAK2 mutation in polycythemia vera

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The Jak2V617F mutation, PRV-1 overexpression, and EEC formation define a similar cohort of MPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Multiple signaling pathways are involved in erythropoietin-independent differentiation of erythroid progenitors in polycythemia vera.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

A human erythropoietin receptor gene mutant causing familial erythrocytosis is associated with deregulation of the rates of Jak2 and Stat5 inactivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Essential thrombocythemia at diagnosis: causes of diagnostic evaluation and presence of positive diagnostic findings

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The JAK2 V617F activating tyrosine kinase mutation is an infrequent event in both "atypical" myeloproliferative disorders and myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Early-stage idiopathic (primary) myelofibrosis--current issues of diagnostic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Hematopathologic findings in chronic idiopathic myelofibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Primary myelofibrosis: a detailed statistical analysis of the clinicopathological variables influencing survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Idiopathic myelofibrosis: pathogenesis, natural history and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis with myeloid metaplasia: clinical and haematological parameters predicting survival in a series of 133 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Dynamics of fibrosis in chronic idiopathic (primary) myelofibrosis during therapy: a follow-up study on 309 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Essential thrombocythaemia: challenges and evidence-based management

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Idiopathic primary osteo-myelofibrosis: a clinico-pathological study on 208 patients with special emphasis on evolution of disease features, differentiation from essential thrombocythemia and variables of prognostic impact.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Clinicopathological diagnosis and differential criteria of thrombocythemias in various myeloproliferative disorders by histopathology, histochemistry and immunostaining from bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Aetiology and clinical significance of thrombocytosis: analysis of 732 patients with an elevated platelet count

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Thrombocytosis in adults: analysis of 777 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Diagnostic and differential criteria of essential thrombocythemia and reactive thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Thrombocytosis and thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Relevance of the criteria commonly used to diagnose myeloproliferative disorder in patients with splanchnic vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Hydroxyurea compared with anagrelide in high-risk essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Progression of essential thrombocythemia to blastic crisis via idiopathic myelofibrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Chronic myeloproliferative disorders in bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Should a platelet limit of 600 x 109/l be used as a diagnostic criterion in essential thrombocythaemia? An analysis of the natural course including early stages

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Prefibrotic chronic idiopathic myelofibrosis--a diagnostic enigma?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) - a clinicopathological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis with myeloid metaplasia in young individuals: disease characteristics, prognostic factors and identification of risk groups

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The changing profile of idiopathic myelofibrosis: a comparison of the presenting features of patients diagnosed in two different decades.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Proposal for revised diagnostic criteria of essential thrombocythemia and polycythemia vera by the Thrombocythemia Vera Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

A long term follow-up of a randomized trial comparing interferon-alpha with busulfan for chronic myelogenous leukemia. The Kouseisho Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Histological and cytological heterogeneity of bone marrow in Philadelphia-positive chronic myelogenous leukaemia at diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis in chronic granulocytic leukaemia: clinicopathologic correlations and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Bone marrow features and clinical findings in chronic myeloid leukemia--a comparative, multicenter, immunohistological and morphometric study on 614 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Changing patterns of histological subgroups during therapy of Ph1+ chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Histological features of prognostic significance in CML--an immunohistochemical and morphometric study (multivariate regression analysis) on trephine biopsies of the bone marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Macrophages and their subpopulations following allogenic bone marrow transplantation for chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Impact of clinical and morphological variables in classification and regression tree-based survival (CART) analysis of CML with special emphasis on dynamic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Evaluating the volume ratio of bone marrow affected by fibrosis: A parameter crucial for the prognostic significance of marrow fibrosis in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Myelofibrosis in chronic myeloproliferative disorders. Incidence among subtypes according to the Hannover Classification

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The relevance of reticulin stain-measured fibrosis at diagnosis in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Proposal for a simple synthesis prognostic staging system in chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Relevance and dynamics of myelofibrosis regarding hematopoietic reconstitution after allogeneic bone marrow transplantation in chronic myelogenous leukemia--a single center experience on 160 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Planimetric analysis of megakaryocytes in the four main groups of chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Bone marrow histopathology predicting blast crisis in chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Polycythemia rubra vera versus secondary polycythemias. A clinicopathological evaluation of distinctive features in 199 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Bone marrow features of diagnostic impact in erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Comparison of molecular markers in a cohort of patients with chronic myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Serum erythropoietin in the diagnosis of polycythaemia and after phlebotomy treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

In vitro culture growth of erythroid progenitors and serum erythropoietin assay in the differential diagnosis of polycythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Patterns of in vitro BFU-E proliferation in different forms of polycythaemia and in thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Spontaneous erythroid colony formation in the differential diagnosis of erythrocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Primary polycythaemia: diagnosis by non-conventional positive criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Comparison of erythroid progenitor cell growth in vitro in polycythemia vera and chronic myelogenous leukemia: only polycythemia vera has endogenous colonies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Polycythemia vera: the natural history of 1213 patients followed for 20 years. Gruppo Italiano Studio Policitemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Pure erythrocytosis: reappraisal of a study of 51 cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The rate of progression to polycythemia vera or essential thrombocythemia in patients with erythrocytosis or thrombocytosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Development of erythrocytosis in the course of essential thrombocythemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Serum erythropoietin and thrombopoietin levels in patients with essential thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Megakaryocyte and erythroid colony formation in essential thrombocythaemia and reactive thrombocytosis: diagnostic value and correlation to complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Histomorphometry of bone marrow biopsies in primary osteomyelofibrosis/-sclerosis (agnogenic myeloid metaplasia)--correlations between clinical and morphological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Evolution of fibro-osteosclerotic bone marrow lesions in primary (idiopathic) osteomyelofibrosis--a histomorphometric study on sequential trephine biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The incidence of myelofibrosis in essential thrombocythaemia, polycythaemia vera and chronic idiopathic myelofibrosis: a retrospective evaluation of sequential bone marrow biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Histomorphometry of bone marrow biopsies in chronic myeloproliferative disorders with associated thrombocytosis--features of significance for the diagnosis of primary (essential) thrombocythaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Quantitation of Bone Marrow Reticulin—A Normal Range

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

The Reticulin Content of Bone Marrow in Acute Leukaemia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Follow-up examinations including sequential bone marrow biopsies in essential thrombocythemia (ET): a retrospective clinicopathological study of 120 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Acute transformation in nonleukemic chronic myeloproliferative disorders: actuarial probability and main characteristics in a series of 218 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

Acute megakaryocytic leukemia in essential thrombocythemia: an unusual evolution?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F10428190500331329

10.1080/10428190500331329

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference